Nothing Special   »   [go: up one dir, main page]

ZA200604020B - Novel compounds - Google Patents

Novel compounds Download PDF

Info

Publication number
ZA200604020B
ZA200604020B ZA200604020A ZA200604020A ZA200604020B ZA 200604020 B ZA200604020 B ZA 200604020B ZA 200604020 A ZA200604020 A ZA 200604020A ZA 200604020 A ZA200604020 A ZA 200604020A ZA 200604020 B ZA200604020 B ZA 200604020B
Authority
ZA
South Africa
Prior art keywords
chloro
benzofuran
piperidin
spiro
propan
Prior art date
Application number
ZA200604020A
Other languages
English (en)
Inventor
Baxter Andrew
Ivanova Svetlana
Pimm Austen
Hossain Nafizal
Mensonides-Harsema Marguerite
Reuberson James
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200604020B publication Critical patent/ZA200604020B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200604020A 2003-11-20 2006-05-18 Novel compounds ZA200604020B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303090A SE0303090D0 (sv) 2003-11-20 2003-11-20 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200604020B true ZA200604020B (en) 2007-12-27

Family

ID=29729113

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200604020A ZA200604020B (en) 2003-11-20 2006-05-18 Novel compounds

Country Status (14)

Country Link
US (1) US7498338B2 (ja)
EP (1) EP1687311A1 (ja)
JP (1) JP2007512323A (ja)
KR (1) KR20060111518A (ja)
CN (1) CN1906200A (ja)
AU (1) AU2004291455B2 (ja)
BR (1) BRPI0416745A (ja)
CA (1) CA2546028A1 (ja)
IL (1) IL175437A0 (ja)
NO (1) NO20062900L (ja)
NZ (1) NZ547259A (ja)
SE (1) SE0303090D0 (ja)
WO (1) WO2005049620A1 (ja)
ZA (1) ZA200604020B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202133D0 (sv) 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) * 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
JP2009526065A (ja) * 2006-02-08 2009-07-16 ワイス C型肝炎ウイルスによる感染を治療するためのスルホンアミド誘導体
CA2657639A1 (en) 2006-07-19 2008-01-24 Astrazeneca Ab Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
US20110136843A1 (en) * 2007-02-23 2011-06-09 Tomas Eriksson Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
WO2008103126A1 (en) * 2007-02-23 2008-08-28 Astrazeneca Ab Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
WO2009011654A1 (en) * 2007-07-17 2009-01-22 Astrazeneca Ab Process for the preparation of cyclic spiropiperidines
WO2009011655A1 (en) * 2007-07-17 2009-01-22 Astrazeneca Ab Splropiperidine compounds, a process of their preparation, pharmaceutical compositions containing them, and their use in the treatment of airway diseases, inflammatory diseases, copd or asthma
WO2009061881A1 (en) * 2007-11-07 2009-05-14 Glaxo Group Limited Spirodihydrobenzofurans as modulators of chemokine receptors
GB0909768D0 (en) * 2009-06-08 2009-07-22 Nanyang Polytechnic Novel compounds and uses thereof
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010201A (en) 1974-04-12 1977-03-01 The Upjohn Company Organic compounds
US4166120A (en) 1978-04-14 1979-08-28 American Hoechst Corporation Analgesic and tranquilizing benzoylpropyl-spiro[dihydrobenzofuran]piperidines and pyrrolidines
US4166119A (en) 1978-04-14 1979-08-28 American Hoechst Corporation Analgesic and tranquilizing spiro[dihydrobenzofuran]piperidines and pyrrolidines
US4263317A (en) 1979-09-06 1981-04-21 Hoechst-Roussel Pharmaceuticals, Inc. Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s
US5366986A (en) 1988-04-15 1994-11-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
DE3930262A1 (de) 1989-09-11 1991-03-21 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5576321A (en) 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
DE59610077D1 (de) 1995-05-18 2003-02-27 Altana Pharma Ag Phenyldihydrobenzofurane
AU5803398A (en) 1996-12-13 1998-07-03 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US5962462A (en) 1996-12-13 1999-10-05 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
CA2278309A1 (en) * 1997-01-21 1998-07-23 Merck & Co., Inc. 3,3-disubstituted piperidines as modulators of chemokine receptor activity
EP1061076B1 (en) 1998-02-04 2004-12-08 Banyu Pharmaceutical Co., Ltd. N-acyl cyclic amine derivatives
US6288083B1 (en) * 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU1244001A (en) 1999-10-27 2001-05-08 Cor Therapeutics, Inc. Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
WO2001064213A1 (en) * 2000-03-02 2001-09-07 Smithkline Beecham Corporation Compounds and methods
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
WO2002102387A1 (en) 2001-06-18 2002-12-27 H. Lundbeck A/S Treatment of neuropathic pain
AU2002363236A1 (en) 2001-10-30 2003-05-12 Millennium Pharmaceuticals, Inc. Compounds, pharmaceutical compositions and methods of use therefor
SE0202133D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
US7247725B2 (en) 2002-10-30 2007-07-24 Merck & Co., Inc. Gamma-aminoamide modulators of chemokine receptor activity
EP1565436B1 (en) 2002-11-27 2012-04-25 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
SE0302755D0 (sv) 2003-10-17 2003-10-17 Astrazeneca Ab Novel compounds
US20070021498A1 (en) 2004-10-14 2007-01-25 Nafizal Hossain Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
SE0302811D0 (sv) 2003-10-23 2003-10-23 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303280D0 (sv) 2003-12-05 2003-12-05 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
BRPI0509307A (pt) 2004-03-29 2007-09-04 Pfizer compostos de alfa aril ou heteroaril metil beta piperidino propanamida como antagonistas do receptor orl1

Also Published As

Publication number Publication date
EP1687311A1 (en) 2006-08-09
JP2007512323A (ja) 2007-05-17
BRPI0416745A (pt) 2007-01-16
IL175437A0 (en) 2006-09-05
US20070129393A1 (en) 2007-06-07
AU2004291455B2 (en) 2008-01-24
CA2546028A1 (en) 2005-06-02
US7498338B2 (en) 2009-03-03
SE0303090D0 (sv) 2003-11-20
WO2005049620A1 (en) 2005-06-02
NO20062900L (no) 2006-08-21
CN1906200A (zh) 2007-01-31
KR20060111518A (ko) 2006-10-27
AU2004291455A1 (en) 2005-06-02
NZ547259A (en) 2009-04-30

Similar Documents

Publication Publication Date Title
ZA200604020B (en) Novel compounds
TWI453019B (zh) 甲醯胺化合物
EP1802623A1 (en) 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
ZA200605082B (en) Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
BRPI0510736B1 (pt) Compostos de amido e composição que os compreende
AU2018221148B2 (en) 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN108025002B (zh) 含有六元氮杂杂环的δ阿片受体调节化合物、其使用和制备方法
CN103664973A (zh) 螺羟吲哚化合物及其作为治疗剂的用途
JP6917379B2 (ja) 8−アミノ−2−オキソ−1,3−ジアザ−スピロ−[4.5]−デカン誘導体
US8410094B2 (en) Amide compounds, their pharmaceutical compositions, their preparation method and their uses
KR20130141434A (ko) 다중 프로스타글란딘 수용체에서 일반적인 항-염증 반응을 제공하는 화합물 작용
TW202321219A (zh) 雜環衍生物及其組合物和藥學上的應用
JP2004524345A (ja) Ccr受容体活性のモジュレーターとしての新規アミド、製法、および治療的使用
KR20030017547A (ko) 신규 화합물
Ma et al. Synthesis and Biological Evaluation of 1, 3, 3, 4‐Tetrasubstituted Pyrrolidine CCR5 Receptor Antagonists. Discovery of a Potent and Orally Bioavailable Anti‐HIV Agent
RU2007102272A (ru) Замещенные дикетопиперазины в качестве антагонистов
ZA200609236B (en) Amido compounds and their use as pharmaceuticals
JP2020508301A (ja) 7員アザ複素環を含有するデルタ−オピオイド受容体調節化合物、その使用方法及び製造方法
AU645866B2 (en) Alkylidene analogs of 1'-aminospiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5' (2H)-tetrones
AU645865B2 (en) 1'-aminospiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5' (2H)-tetrones and analogs thereof
US20230303531A1 (en) 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
JP2022527080A (ja) セロトニン5-ht2b阻害化合物
ZA200206402B (en) Novel compounds.
JP2005501866A (ja) ケモカイン受容体活性のモジュレーターとしての新規ピペリジニル誘導体
CN103159754A (zh) 一种氨基丙基取代托烷胺类化合物、其药物组合物及其制备方法和用途